Abstract:e23123 Background: Pleural carcinosis caused by tumors of the chest (e.g., lung and breast cancer) or elsewhere in the body (e.g., ovarian carcinoma) that metastasize to the visceral and/or parietal pleura. Recurrent malignant pleural effusion due to pleural carcinosis is one of the most common findings in oncology. The aim of the study was to identify a miRNA signature associated with clinicians’ prescription of patients with MPE. Methods: We used qRT-PCR assay to evaluate a wide range miRNAs (1920 miRNAs) signature measured from pleural effusion between patients with cancer and healthy controls. From the data of our previous studies we selected a panel of 96 miRNAs related to malignant pleural effusion. Data were compared by three classification methods software for statistics and modeling. We used a first set of 77 pleural effusion samples as training group, including 27 patients affected by Lung Adenocarcinomas (LAC), 9 with other lung cancer, 17 with other tumors and 24 inflammatory patients as negative controls. Moreover, we used more 64 pleural effusion samples for double-blind predictive study. Data analysis was performed using a machine learning approach of a Support Vector Machine classifier with a Student's t-test feature selection procedure. Results: We identified a panel of ten miRNAs with optimum classification performance. The combination of these 10-miRNAs alone could discriminate MPE cases from negative controls with an AUC of 0.969 (accuracy = 93.5%; specificity = 91.7%). The selected panel of another 10-miRNAs could separate lung cancer cases from negative controls with an AUC of 0.973 (accuracy = 94.8%; specificity = 95.8%), and a small panel of 4-miRNAs could good discriminate LAC cases from negative controls with an AUC of 0.946 (accuracy 88.9%; specificity = 100%). The accuracy rate of the double-blind predictive sensitivity value was 90.9% and specificity value was 95.8% for MPE patients with lung cancer of miRNA signature. Conclusions: Our miRNAs profile may serve as a new biomarker for MPE diagnosis. Otherwise, we identified a 10-miRNAs signature for MPE patients with lung cancer and a 4-miRNAs for MPE patients with lung adenocarcinoma.

Generation and Differentiation of IL-17–Producing CD4+ T Cells in Malignant Pleural Effusion

CD39+ Regulatory T Cells Suppress Generation and Differentiation of Th17 Cells in Human Malignant Pleural Effusion Via a LAP-dependent Mechanism

Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.

Cell Origins and Significance of IL-17 in Malignant Pleural Effusion

Imbalance of Th17 Cells and Regulatory T Cells in Tuberculous Pleural Effusion.

Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion

Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion.

Th17/Treg imbalance in malignant pleural effusion

Activated naïve B cells promote development of malignant pleural effusion by differential regulation of TH1 and TH17 response.

IL‐10 promotes malignant pleural effusion in mice by regulating TH1‐ and TH17‐cell differentiation and migration

Recruitment and Phenotypic Characteristics of Interleukin 9-Producing CD4+ T Cells in Malignant Pleural Effusion

IL-10 promotes malignant pleural effusion in mice by regulating TH 1- and TH 17-cell differentiation and migration

Recruitment of IL ‐1β‐producing intermediate monocytes enhanced by C5a contributes to the development of malignant pleural effusion

C5a enhances inflammation and chemotaxis of γδ T cells in malignant pleural effusion

Immune Regulation of Interleukin-27 in Malignant Pleural Effusion

Helper T cells in malignant pleural effusion

Differentiation and Recruitment of IL-22-producing Helper T Cells Stimulated by Pleural Mesothelial Cells in Tuberculous Pleurisy.

Single-cell analysis of diverse immune phenotypes in malignant pleural effusion

Non-classical Monocytes Potentiates the Pathogenesis of Malignant Pleural Effusion Via the Production of IL-1ß

221P Single-cell Transcriptomics Reveals CLDN4+ Cancer Cells Underlying the Recurrence of Malignant Pleural Effusion in Patients with Advanced Non-Small Cell Lung Cancer

Genome-wide Microrna Expression Profiling in Malignant Pleural Effusion to Identify a Ten-Microrna Signature.